Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 44401-44402 [E9-20813]

Download as PDF Federal Register / Vol. 74, No. 166 / Friday, August 28, 2009 / Notices Dated: August 26, 2009. Henry C. Pitney, (Acting) Vice President and General Counsel, Millennium Challenge Corporation. [FR Doc. E9–20944 Filed 8–26–09; 4:15 pm] BILLING CODE 9211–03–P NATIONAL SCIENCE FOUNDATION Advisory Committee for International Science & Engineering; Notice of Meeting In accordance with Federal Advisory Committee Act (Pub. L. 92–463, as amended), the National Science Foundation announces the following meeting: Name: Advisory Committee for International Science and Engineering (#25104). Date/Time: September 28, 2009; 8:30 a.m. to 5 p.m.; September 29, 2009; 8:30 a.m. to 12 p.m. Place: National Science Foundation, 4201 Wilson Boulevard, Room 920, Arlington, VA. Type of Meeting: Open. Contact Person: Edward Murdy, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230 (703) 292–8710. If you are attending the meeting and need access to the NSF, please contact the individual listed above so you name may be added to the building access list. Purpose of Meeting: To provide advice on the programs and activities of the Office of International Science and Engineering. Agenda: September 28, 2009 AM: Introductions and Updates— Presentation and Discussion of 2009 activities. PM: Presentation and Discussion—Meet with NSF Director; Committee Discussion. September 30, 2009 AM: Presentation and Discussion— Activities and initiatives for the coming year. Planning for the next meeting. Nadene G. Kennedy, Permit Officer. [FR Doc. E9–20734 Filed 8–27–09; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Call for Nominations AGENCY: U.S. Nuclear Regulatory Commission. ACTION: Call for Nominations. ACTION: SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising for nominations for the nuclear medicine physician position and the radiation oncologist position on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nuclear medicine physician nominees should currently be practicing nuclear medicine in a clinical setting. Radiation oncologist nominees should currently be practicing radiation oncology to include clinical use of the Gamma Knife® unit. DATES: Nominations are due on or before October 27, 2009. Nomination Process: Submit an electronic copy of resume or curriculum vitae, along with a cover letter, to Ms. Ashley Cockerham, ashley.cockerham@nrc.gov. The cover letter should describe the nominee’s current duties and responsibilities and express the nominee’s interest in the position. Please ensure that resume or curriculum vitae includes the following information, if applicable: Education; certification; professional association membership and committee membership activities; duties and responsibilities in current and previous clinical, research, and/or academic position(s). SUMMARY: The National Science Foundation (NSF) is required to publish notice of permits issued under the Antarctic Conservation Act of 1978. This is the required notice. FOR FURTHER INFORMATION CONTACT: Ms. Ashley Cockerham, U.S. Nuclear Regulatory Commission, Office of Federal and State Materials and Environmental Management Programs; (240) 888–7129; ashley.cockerham@nrc.gov. Dated: August 25, 2009. Susanne Bolton, Committee Management Officer. [FR Doc. E9–20771 Filed 8–27–09; 8:45 am] BILLING CODE 7555–01–P NATIONAL SCIENCE FOUNDATION Notice of Permits Issued Under the Antarctic Conservation Act of 1978 National Science Foundation. Notice of permits issued under the Antarctic Conservation Act of 1978, Public Law 95–541. AGENCY: hsrobinson on DSK69SOYB1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Nadene G. Kennedy, Permit Office, Office of Polar Programs, Rm. 755, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230. SUPPLEMENTARY INFORMATION: On July 15, 2009, the National Science Foundation published a notice in the Federal Register of a permit application received. A permit was issued on August 24, 2009 to: Charles D. Amsler, Jr., Permit No. 2010–007. VerDate Nov<24>2008 21:38 Aug 27, 2009 Jkt 217001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 44401 The ACMUI nuclear medicine physician provides advice to NRC staff on issues associated with the regulation of diagnostic and therapeutic applications of byproduct material. This advice includes providing input on NRC proposed rules and guidance documents, providing recommendations on the training and experience requirements for physicians specializing in diagnostic and therapeutic nuclear medicine, identifying medical events associated with these uses, evaluating non-routine medical uses of byproduct material, bringing key issues in the nuclear medicine community to the attention of NRC staff, and other nuclear medicine issues as they relate to radiation safety and NRC medical-use policy. The ACMUI Gamma Stereotactic Radiosurgery (GSR) radiation oncologist provides advice on issues associated with radiation oncology and the clinical use of GSR. This advice includes providing input on NRC proposed rules and guidance documents, providing recommendations on the training and experience requirements for physicians specializing in this use, identifying medical events associated with this use, evaluating new models of GSR units, bringing key issues in the radiation oncology community to the attention of NRC staff, and other radiation oncology issues as they relate to radiation safety and NRC medical-use policy. ACMUI members are selected based on their educational background, certification(s), work experience, involvement and/or leadership in professional society activities, and other information obtained in letters or during the selection process. ACMUI members currently serve a four-year term and may be considered for reappointment to an additional term. The current membership is comprised of the following professionals: (a) Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear medicine physicist; (d) therapy medical physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) patients’ rights advocate; (i) Food and Drug Administration representative; (j) Agreement State representative; and (k) health care administrator. For additional information about membership on the ACMUI, visit the ACMUI Membership Web page, http://www.nrc.gov/aboutnrc/regulatory/advisory/acmui/ membership.html. Nominees must be U.S. citizens and be able to devote approximately 160 hours per year to Committee business. Members are expected to attend semi- SUPPLEMENTARY INFORMATION: E:\FR\FM\28AUN1.SGM 28AUN1 44402 Federal Register / Vol. 74, No. 166 / Friday, August 28, 2009 / Notices annual meetings in Rockville, Maryland and to participate in teleconferences, as needed. Members who are not Federal employees are compensated for their service. In addition, these members are reimbursed for travel and correspondence expenses. Full-time Federal employees are reimbursed travel expenses only. Security Background Check: The selected nominee will undergo a thorough security background check. Security paperwork may take the nominee several weeks to complete. Nominees will also be required to complete a financial disclosure statement to avoid conflicts of interest. Dated at Rockville, Maryland, this 24th day of August 2009. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. E9–20813 Filed 8–27–09; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No.: 07007001; NRC–2009–0377; Certificate No. GDP–1; EA–08–344] United States Enrichment Corporation, Paducah Gaseous Enrichment Plant; Confirmatory Order (Effective Immediately) hsrobinson on DSK69SOYB1PROD with NOTICES I The United States Enrichment Corporation (USEC), a subsidiary of USEC Inc., is the holder of NRC Certificates of Compliance (COC) No. GDP–1 issued by the NRC pursuant to 10 CFR Part 76 on November 26, 1996, and renewed on December 22, 2008. The COC is set to expire on December 31, 2013. The certificate authorizes USEC to operate the Paducah Gaseous Diffusion Plant (Paducah), located near Paducah, Kentucky. The certificate also authorizes USEC to receive, and other NRC licensees to transfer to USEC, byproduct material, source material, or special nuclear material to the extent permitted under the COC. This Confirmatory Order is the result of an agreement reached during an alternative dispute resolution (ADR) mediation session conducted on July 2, 2009. II On December 5, 2008, the NRC’s Office of Investigations (OI) completed an investigation (OI Case No. 2–2008– 023) regarding activities at the Paducah Gaseous Diffusion Plant located in Paducah, Kentucky. The purpose of the VerDate Nov<24>2008 21:38 Aug 27, 2009 Jkt 217001 investigation was to determine whether one or more operators deliberately concealed damaged equipment, falsified records, and made false statements to conceal a procedural error while moving a uranium hexafluoride (UF6) cylinder. Based on the evidence developed during the investigation, the NRC staff identified four apparent violations. III On July 2, 2009, the NRC and USEC met in an ADR session mediated by a professional mediator, which was arranged through Cornell University’s Institute on Conflict Resolution. ADR is a process in which a neutral mediator with no decision-making authority assists the parties in reaching an agreement or resolving any differences regarding their dispute. This confirmatory order is issued pursuant to the agreement reached during the ADR process. The elements of the agreement consist of the following: 1. The NRC and USEC agreed that four violations occurred during and subsequent to an incident that occurred in late January 2008, while an operator was preparing a UF6 cylinder for movement using the applicable procedure. The violations involved the following: a. On January 29, 2008, an Operator in building C–337A failed to follow Step 8.7.37 of checklist ‘‘Cylinder Burping and Cold Pressure Procedure’’ incorporated into procedure USEC CP4– CO–CN2045a that required that the pigtail be disconnected from the cylinder and the autoclave manifold prior to cylinder movement. As a result, the pigtail and the autoclave manifold were damaged when the cylinder was lifted. In addition, the same Operator subsequently willfully placed a waste pigtail in a radioactive waste storage bag and hid it in an unrelated control panel, instead of storing the waste pigtail in a drum and completing the required documentation in accordance with the requirements of USEC Procedure CP4– CO–CN2045a, Step 5.27.3. USEC Procedure CP4–CO–CN2045a is required by Technical Safety Requirements 3.1.1, ‘‘Procedures Scope,’’ which requires, in part, that written procedures shall be implemented to cover activities listed in Appendix A to Safety Analysis Report (SAR) section 6.11. Appendix A to SAR 6.11, ‘‘Organization and Operating Programs,’’ lists UF6 cylinder handling as an activity that requires implementation of written procedures. b. On January 29, 2008, an Operator in the C–337A building willfully did not take any action to secure the damaged autoclave manifold, contact the PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 appropriate supervisor or manager, or log the damage in a work package, narrative logbook, or other quality record. The Operator also willfully attempted to repair the autoclave manifold so as to conceal the initial failure to disconnect the pigtail from the autoclave manifold and the cylinder. In addition, a second Operator failed to contact the appropriate supervisor or manager upon learning of an incident that resulted in damage to both the pigtail and the autoclave manifold, and an Operator-Trainee in the C–337A building also failed to contact the appropriate supervisor or manager upon witnessing the incident. The actions of the two Operators and Operator-Trainee are contrary to USEC procedures CP2– PS–PS1044, ‘‘Use of Procedures’’, and CP2–CO–CO1032, ‘‘Shift Routines and Operating Practices.’’ c. On January 29, 2008, an Operator in the C–337A building willfully prepared and signed his name (i.e., falsified) on a document, indicating that the pigtail had been properly disconnected from the autoclave manifold, when in fact the Operator knew that the pigtail had not been properly disconnected and was damaged. A second Operator in the C– 337A building also willfully signed his name (i.e., falsified) on a document, with knowledge that the pigtail had not been properly disconnected from the autoclave. The falsification of documents is prohibited by USEC Procedure UE2–OP–OP1030, ‘‘Conduct of Operation.’’ d. On January 30, 2008, two Operators and an Operator-Trainee, individuals who were familiar with the circumstances that resulted in damage to an autoclave manifold, willfully denied any knowledge of these circumstances when questioned by Corporation management. These actions are contrary to USEC Procedure UE2– OP–OP1030, ‘‘Conduct of Operation.’’ 2. At the ADR session, USEC– Paducah representatives agreed that the circumstances described in Item 1 above represent violations of requirements, and were due, in part, to the willful actions of the two Operators and an Operator-Trainee. 3. Based on USEC–Paducah’s review of the incident and NRC concerns with respect to precluding recurrence of the violations, USEC took the following actions: a. In January 2008, cylinders potentially affected by the incident were inspected. b. In February 2008, the Nuclear Safety & Quality organization began conducting surveillances of in-hand E:\FR\FM\28AUN1.SGM 28AUN1

Agencies

[Federal Register Volume 74, Number 166 (Friday, August 28, 2009)]
[Notices]
[Pages 44401-44402]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20813]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the nuclear medicine physician position and the 
radiation oncologist position on the Advisory Committee on the Medical 
Uses of Isotopes (ACMUI). Nuclear medicine physician nominees should 
currently be practicing nuclear medicine in a clinical setting. 
Radiation oncologist nominees should currently be practicing radiation 
oncology to include clinical use of the Gamma Knife[supreg] unit.

DATES: Nominations are due on or before October 27, 2009.
    Nomination Process: Submit an electronic copy of resume or 
curriculum vitae, along with a cover letter, to Ms. Ashley Cockerham, 
ashley.cockerham@nrc.gov. The cover letter should describe the 
nominee's current duties and responsibilities and express the nominee's 
interest in the position. Please ensure that resume or curriculum vitae 
includes the following information, if applicable: Education; 
certification; professional association membership and committee 
membership activities; duties and responsibilities in current and 
previous clinical, research, and/or academic position(s).

FOR FURTHER INFORMATION CONTACT: Ms. Ashley Cockerham, U.S. Nuclear 
Regulatory Commission, Office of Federal and State Materials and 
Environmental Management Programs; (240) 888-7129; 
ashley.cockerham@nrc.gov.

SUPPLEMENTARY INFORMATION: The ACMUI nuclear medicine physician 
provides advice to NRC staff on issues associated with the regulation 
of diagnostic and therapeutic applications of byproduct material. This 
advice includes providing input on NRC proposed rules and guidance 
documents, providing recommendations on the training and experience 
requirements for physicians specializing in diagnostic and therapeutic 
nuclear medicine, identifying medical events associated with these 
uses, evaluating non-routine medical uses of byproduct material, 
bringing key issues in the nuclear medicine community to the attention 
of NRC staff, and other nuclear medicine issues as they relate to 
radiation safety and NRC medical-use policy.
    The ACMUI Gamma Stereotactic Radiosurgery (GSR) radiation 
oncologist provides advice on issues associated with radiation oncology 
and the clinical use of GSR. This advice includes providing input on 
NRC proposed rules and guidance documents, providing recommendations on 
the training and experience requirements for physicians specializing in 
this use, identifying medical events associated with this use, 
evaluating new models of GSR units, bringing key issues in the 
radiation oncology community to the attention of NRC staff, and other 
radiation oncology issues as they relate to radiation safety and NRC 
medical-use policy.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process. ACMUI members currently serve 
a four-year term and may be considered for reappointment to an 
additional term. The current membership is comprised of the following 
professionals: (a) Nuclear medicine physician; (b) nuclear 
cardiologist; (c) nuclear medicine physicist; (d) therapy medical 
physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) 
two radiation oncologists; (h) patients' rights advocate; (i) Food and 
Drug Administration representative; (j) Agreement State representative; 
and (k) health care administrator. For additional information about 
membership on the ACMUI, visit the ACMUI Membership Web page, http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members are expected to 
attend semi-

[[Page 44402]]

annual meetings in Rockville, Maryland and to participate in 
teleconferences, as needed. Members who are not Federal employees are 
compensated for their service. In addition, these members are 
reimbursed for travel and correspondence expenses. Full-time Federal 
employees are reimbursed travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland, this 24th day of August 2009.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E9-20813 Filed 8-27-09; 8:45 am]
BILLING CODE 7590-01-P